CML
Filters
All Videos
Total Health
Advances in Leukemia: Targeted Therapies and Immunotherapy
FEATURING
Jorge Cortés
- 2 views
- March 10, 2025
International CML Foundation
Highlights of ASH 2024: Key CML Oral Presentations
FEATURING
Timothy Hughes
- 3 views
- March 6, 2025
International CML Foundation
Highlights of ASH 2024: CML Biology Overview
FEATURING
Susan Branford
- 2 views
- March 6, 2025
Tisch Cancer Institute at Mount Sinai
Leukemia Tumor Board: Navigating Ambiguous Leukemia - CML-BP/MPAL
FEATURING
Justine Anderson
- 12 views
- February 6, 2025
Cleveland Clinic Taussig Cancer Institute
ASH 2024 Review: Practice-Changing Updates in the Management of CML
FEATURING
Akriti Jain
- 202 views
- February 3, 2025
- 2
Oncology 2024 Year in Review
Year in Review 2024: CML Highlights
FEATURING
Jorge Cortés
- 110 views
- January 29, 2025
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Highlights in CML
FEATURING
Jay Yang
- 322 views
- January 9, 2025
- 2
Winship Cancer Institute - Emory University
FDA Approved First Oral Solution of Imatinib
FEATURING
Aseala Abousaud
- 54 views
- December 13, 2024
- 1
International CML Foundation
ESH-iCMLf 26th Goldman Conference Highlights on CML: Biological Updates
FEATURING
Daniela Krause
- 9 views
- December 4, 2024
International CML Foundation
ESH-iCMLf 26th Goldman Conference Highlights on CML: Clinical Updates
FEATURING
Jorge Cortés
- 17 views
- December 2, 2024
Total Health
Fast Five Key Updates in Malignant Heme: Pearls From a Pharmacist
FEATURING
Sarah Medeiros
- 281 views
- November 26, 2024
- 2
ecancer
Selecting the Best Tyrosine Kinase Inhibitors for Chronic-Phase CML Patients
FEATURING
Prashant Mehta
- 17 views
- November 18, 2024
Yale Cancer Center
Myeloid Malignancies: Hot Topics in 2024
FEATURING
Nikolai Podoltsev
- 378 views
- October 21, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
CML Case Discussion: Elderly Patients not Meeting ELN Milestones
FEATURING
Mohamed Isam Sharif
- 11 views
- October 15, 2024
Masonic Cancer Center, University of Minnesota
Blood Cancers Basics
FEATURING
Zohar Sachs
- 39 views
- October 7, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
How I Treat R/R CML in 2024: Strategies and Emerging Therapies
FEATURING
Elias Jabbour
- 27 views
- September 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
TKI Discontinuation in CML: Defining Eligibility Criteria and Predictors of Success
FEATURING
Mohamed A. Yassin
- 31 views
- September 25, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 584 views
- September 23, 2024
- 2
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Critical Re-Evaluation of Established Practices in CML Management
FEATURING
Hagop Kantarjian
- 189 views
- September 16, 2024
- 1
Houston Methodist
Current Treatment Landscape in Myeloid Malignancies
FEATURING
Shilpan Shah
- 63 views
- September 11, 2024
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: CML, AML, ALL
FEATURING
Mariam Nawas
- 45 views
- September 3, 2024
MyCancerHaven
Experts Discuss How They Use Asciminib in Their CML Practice
FEATURING
Ravi Vij,
Joshua Zeidner
- 180 views
- September 3, 2024
2024 ASCO® Annual Meeting Insights Hub
Highlights of Recent Updates in CML: Impact on Practice
FEATURING
Ehab Atallah
- 56 views
- August 27, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
TKI Toxicity Management in CML: A Case-Based Discussion
FEATURING
Awni Alshurafa
- 25 views
- August 15, 2024
International CML Foundation
Biological Highlights in CML From EHA
FEATURING
Nick Cross
- 50 views
- August 9, 2024
International CML Foundation
Clinical Highlights in CML From EHA
FEATURING
Andreas Hochhaus
- 49 views
- August 9, 2024
Insights from 2024 EHA Annual Meeting
AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024
FEATURING
Talha Badar
- 821 views
- July 16, 2024
- 4
Yale Cancer Center
Challenges in Management of Older Patients With CML
FEATURING
Nikolai Podoltsev
- 48 views
- July 5, 2024
Rush University Medical Center
[duplicate] Is Post-HSCT Maintenance the SOC for AML?
FEATURING
Mark Levis
- May 29, 2024
Rush University Medical Center
Is Post-HSCT Maintenance the SOC for AML?
FEATURING
Mark Levis
- 346 views
- May 29, 2024
- 4
Winship Cancer Institute - Emory University
Updates on Myeloproliferative Neoplasms Including CML
FEATURING
Anthony Hunter
- 153 views
- May 7, 2024
Indy Hematology Review
Understanding and Addressing the Challenges in CML in 2024
FEATURING
Richard Larson
- 79 views
- May 3, 2024
Indy Hematology Review
Controversies in the Management of CML in 2024
FEATURING
Richard Larson
- 118 views
- April 17, 2024
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignancies
FEATURING
Ruemu Birhiray
- 974 views
- April 16, 2024
- 5
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: CML
FEATURING
Philippe Rousselot
- 66 views
- March 29, 2024
i3 Health
MRD Testing in Leukemias: When Negativity Is a Positive Thing
FEATURING
Noopur S. Raje
- 485 views
- March 15, 2024
- 1
City of Hope
Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Targeted Strategies
FEATURING
Idoroenyi Amanam
- 221 views
- March 11, 2024
- 1
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
FEATURING
Robert Peter Gale
- 4,721 views
- February 26, 2024
- 21
International CML Foundation
Biological Updates in CML From ASH 2023
FEATURING
Michael Deininger
- 39 views
- February 22, 2024
International CML Foundation
Clinical Updates in CML From ASH 2023
FEATURING
Naranie Shanmuganathan
- 65 views
- February 22, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Future Perspectives in CML
FEATURING
Naeem Chaudhri
- 17 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Debates in CML: Imatinib is NOT the Best Choice for 1L TKI
FEATURING
Tomasz Sacha
- 12 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Debates in CML: Imatinib is the Best Choice for 1L TKI
FEATURING
Giuseppe Saglio
- 10 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
CML Case Presentation: A Patient With Multiple TKI Failure
FEATURING
Deniz Özmen İbiş
- 12 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
CML Case Presentation: A Young Patient With TKI Intolerance and Resistance
FEATURING
Carmen Fava
- 12 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
CML: State-of-the-Art and Progress Towards Cure
FEATURING
Pia Raanani
- 15 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Therapeutic Challenges and BMT in Pediatric Patients With CML
FEATURING
Talia Ileri
- 9 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Pediatric CML Treatment Options and Management
FEATURING
ÖZlem TüFekçI GüRocak
- 15 views
- February 16, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Pediatric CML Diagnosis
FEATURING
Adalet Meral Güneş
- 11 views
- February 15, 2024
Akriti Jain
Managing TKI AEs in CML: Thrombocytopenia, Hypertension, Pancreatic Toxicity
- 94 views
- January 10, 2024
- 3
Insights from 2023 ASH Annual Meeting
Treatment Strategies for Hematocrit Control in PV
FEATURING
Amy Zhou
- 955 views
- January 8, 2024
- 6
Insights from 2023 ASH Annual Meeting
Chronic GVHD: Results from Agave-201 - Axatilimab at 3 Different Doses
FEATURING
Daniel Wolff
- 109 views
- December 29, 2023
International CML Foundation
iCMLf Conversations Highlights of the 25th John Goldman Conference: Clinical Overview
FEATURING
Jorge Cortés
- 15 views
- December 29, 2023
International CML Foundation
iCMLf Conversations Highlights of the 25th John Goldman Conference: Biological Overview
FEATURING
Daniela Krause
- 10 views
- December 29, 2023
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "PROs From BMT CTN 1703 Study in GVHD Prophylaxis - a QoL Evaluation"
FEATURING
Shernan Holtan
- 27 views
- December 22, 2023
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "ALLG CML13 ASCEND-CML Study - Asciminib Treatment for 1L CP-CML"
FEATURING
David Yeung
- 125 views
- December 20, 2023
Insights from 2023 ASH Annual Meeting
Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis
FEATURING
Douglas Tremblay
- 436 views
- December 13, 2023
- 1
Jorge Cortés
Unmet Needs in CML: Patient & Physician Perspectives From the CML SUN Study
- 82 views
- December 11, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: WHO 2022 Classification of MPNs - Transitioning From the Optical Into the Molecular Era
FEATURING
Hanan Hamed
- 25 views
- November 27, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: CML and Pregnancy
FEATURING
Elisabetta Abruzzese
- 73 views
- November 21, 2023
The University of Alabama at Birmingham School of Medicine
Treating CML Patients With TKI Resistance vs. TKI Intolerance
FEATURING
Omer Jamy
- 298 views
- November 13, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: CML
FEATURING
Philippe Rousselot
- 28 views
- October 19, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Genomic Complexity Beyond BCR::ABL1 and Its Clinical Impact
FEATURING
David Ross
- 26 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Epigenetic Dysregulation of CML
FEATURING
Tiong Ong
- 31 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: The New ELN Laboratory Recommendations for the Diagnosis and Management of CML
FEATURING
Nick Cross
- 431 views
- October 18, 2023
- 3
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Navigating the Treatment Value of TKIs in CML in the Era of Generics
FEATURING
Hagop Kantarjian
- 40 views
- October 13, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Rational TKI Choice in CML
FEATURING
Michael Deininger
- 309 views
- October 9, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: CML - Are We Doing It Right?
FEATURING
Jorge Cortés
- 354 views
- October 6, 2023
- 1